Castleview Partners’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,204
Closed -$296K 949
2024
Q1
$296K Buy
+16,204
New +$296K 0.17% 138